40 results on '"Topkan, Erkan"'
Search Results
2. Periodontitis can Negatively Impact the Survival Outcomes of Cancer Patients
3. Comment on Survivin -31G/C polymorphism and disease fate in of oral squamous cell carcinomas
4. In reply to Melachuri et al. (https://doi.org/10.1016/j.oraloncology.2024.106703)
5. Pre-chemoradiotherapy high platelet counts predict jaw osteoradionecrosis in locally advanced nasopharyngeal carcinoma patients
6. Letter re: Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial
7. Re: Minimum detectable change in occlusal load – Normative data for healthy and head and neck cancer populations
8. RE: Fibular free flap necrosis after mandibular reconstruction surgery with osteoradionecrosis: Establishment and verification of an early warning model
9. In reply to Chatzopoulos et. al (https://doi.org/10.1016/j.jormas.2022.10.013)
10. Radiation therapy for cT1-2 carcinoma of the palatine tonsil diagnosed via a simple tonsillectomy: Dosimetry and patterns of care in the IMRT era
11. Comments on “Accounting for fractionation and heterogeneous dose distributions in the modelling of osteoradionecrosis in oropharyngeal carcinoma treatment’’
12. Comment on: The extent of unnecessary tooth loss due to extractions prior to radiotherapy based on radiation field and dose in patients with head and neck cancer
13. RE: What Risk Factors Are Associated With Poorer Quality of Life in Patients with Head and Neck Cancer?
14. Letter to the Editor regarding “Radiologic findings of osteonecrosis, osteoradionecrosis, osteomyelitis and jaw metastatic disease with cone beam CT”
15. Comment on: Planned dose of intensity modulated proton beam therapy versus volumetric modulated arch therapy to tooth-bearing regions
16. Letter to the editor: Early detection of mandible osteoradionecrosis risk in a high comorbidity veteran population
17. In Regard to Anderson et al.
18. RE: Is Dose Volume a Better Predictor of Osteoradionecrosis Risk Than Total Dose for Patients Who Have Received Head and Neck Radiation?
19. Comment on: Required time for pre-oncological dental management – A rapid review of the literature
20. Comment on: Osteoradionecrosis after postoperative radiotherapy for oral cavity cancer: A retrospective cohort study
21. Comment on: Risk factors for osteoradionecrosis of the jaw in patients with oral or oropharyngeal cancer: Verification of the effect of tooth extraction before radiotherapy using propensity score matching analysis
22. Lung Cancer in Turkey
23. Comments on Dinnoo et al., 2021: ‘‘18F-FDG PET/CT for early response assessment of jaw osteoradionecrosis after the PENTOCLO protocol: A promising imaging modality’’
24. In regard to recent published study of Massaccesi et al. titled ‘A predictive nomogram for trismus after radiotherapy for head and neck cancer’. (Radiother Oncol. 2022 Jun 2: S0167-8140(22)04137-8. doi: 10.1016/j.radonc.2022.05.031)
25. Prognostic value of pretreatment Glasgow prognostic score in stage IIIB geriatric non-small cell lung cancer patients undergoing radical chemoradiotherapy
26. Local control and vertebral compression fractures following stereotactic body radiotherapy for spine metastases
27. Epoetin receptor status may alter the outcomes in head and neck cancers treated with radiotherapy and darbepoetin-α
28. In Regard to Ward et al
29. Incidence and Impact of Pretreatment Tumor Cavitation on Survival Outcomes of Stage III Squamous Cell Lung Cancer Patients Treated With Radical Concurrent Chemoradiation Therapy
30. Chemoradiotherapy-induced hemoglobin nadir values and survival in patients with stage III non-small cell lung cancer
31. Impact of presence and degree of pretreatment weight loss in locally-advanced pancreatic cancer patients treated with definitive concurrent chemoradiotherapy
32. Safety and Palliative Efficacy of Single-Dose 8-Gy Reirradiation for Painful Local Failure in Patients With Stage IV Non-Small Cell Lung Cancer Previously Treated With Radical Chemoradiation Therapy
33. Definitive Chemoradiation Therapy Following Surgical Resection or Radiosurgery Plus Whole-Brain Radiation Therapy in Non-Small Cell Lung Cancer Patients With Synchronous Solitary Brain Metastasis: A Curative Approach
34. Impact of Weight Change During the Course of Concurrent Chemoradiation Therapy on Outcomes in Stage IIIB Non-Small Cell Lung Cancer Patients: Retrospective Analysis of 425 Patients
35. Outcomes of aggressive concurrent radiochemotherapy in highly selected septuagenarians with stage IIIB non-small cell lung carcinoma: Retrospective analysis of 89 patients
36. In Regard to Bjerregaard et al
37. Impact of omission of elective nodal irradiation on treatment outcomes in locally advanced pancreatic adenocarcinoma patients treated with definitive concurrent chemoradiotherapy
38. Impact of Prophylactic Cranial Irradiation Timing on Brain Relapse Rates in Patients With Stage IIIB Non–Small-Cell Lung Carcinoma Treated With Two Different Chemoradiotherapy Regimens
39. P-0120 Prognostic Value of Gross Tumor Volume Delineated by Fdg-Pet-Ct-Based Radiotherapy Treatment Planning Locally Advanced Pancreatic cancer Treated with Chemoradiotherapy
40. Prevention of acute radiation-induced esophagitis with glutamine in non-small cell lung cancer patients treated with radiotherapy: Evaluation of clinical and dosimetric parameters
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.